Levocetirizina Krka

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizina Krka, is a second‑generation antihistamine presented as an oral dosage form for oral use. It reduces histamine‑mediated symptoms such as itching, sneezing, and runny nose in patients with allergic rhinitis and chronic idiopathic urticaria.

GNH USA supplies Levocetirizina Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Products are manufactured under GMP conditions and undergo comprehensive testing before release.

Levocetirizine Dihydrochloride is used to treat allergic conditions by selectively blocking peripheral H1 receptors, thereby mitigating histamine‑driven symptoms. - Allergic rhinitis: Provides relief from sneezing, nasal congestion, itching, and watery discharge caused by seasonal or perennial allergens, improving daily comfort. - Chronic idiopathic urticaria: Decreases the number and intensity of hives and associated itching, helping patients achieve better symptom control.

Levocetirizina Krka may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild headache reported in some patients. - Dry mouth: sensation of oral dryness. - Drowsiness: occasional mild sedation, less frequent than first‑generation antihistamines.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue requiring immediate medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare systemic allergic reaction that can be life‑threatening.

Levocetirizina Krka should be used with caution in certain situations. - Pregnancy: consult a healthcare provider; safety not established. - Breastfeeding: may be excreted in milk; use only if benefits outweigh risks. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Elderly: monitor for increased sedation or dizziness. - Avoid alcohol: concurrent use may enhance drowsiness. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Levocetirizina Krka can interact with other substances; some require avoidance while others need monitoring.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase levocetirizine plasma levels, raising risk of side effects. - Alcohol and other central nervous system depressants: can cause excessive drowsiness or sedation.

Moderate Interactions (Monitor Closely): - Theophylline: may reduce antihistamine efficacy. - Ritonavir: may elevate levocetirizine concentrations. - Concurrent antihistamines: additive antihistaminic effect may increase risk of sedation.